Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial

BACKGROUND: Recently, long-acting injection (LAI) of second-generation antipsychotics has become a valuable strategy for the treatment of schizophrenia. However, few studies have compared the effects of different LAI antipsychotics on cognitive functions so far. The present study aimed to compare th...

Descripción completa

Detalles Bibliográficos
Autores principales: Takekita, Yoshiteru, Koshikawa, Yosuke, Fabbri, Chiara, Sakai, Shiho, Sunada, Naotaka, Onohara, Ai, Nishida, Keiichiro, Yoshimura, Masafumi, Kato, Masaki, Serretti, Alessandro, Kinoshita, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884618/
https://www.ncbi.nlm.nih.gov/pubmed/27236412
http://dx.doi.org/10.1186/s12888-016-0883-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884618/
https://www.ncbi.nlm.nih.gov/pubmed/27236412
http://dx.doi.org/10.1186/s12888-016-0883-9

Ejemplares similares